rs753472891
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_000199.5(SGSH):βc.703G>Aβ(p.Asp235Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,608,590 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (β β ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D235V) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000199.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SGSH | NM_000199.5 | c.703G>A | p.Asp235Asn | missense_variant | 6/8 | ENST00000326317.11 | NP_000190.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SGSH | ENST00000326317.11 | c.703G>A | p.Asp235Asn | missense_variant | 6/8 | 1 | NM_000199.5 | ENSP00000314606.6 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152226Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000168 AC: 4AN: 237402Hom.: 0 AF XY: 0.0000232 AC XY: 3AN XY: 129136
GnomAD4 exome AF: 0.0000124 AC: 18AN: 1456364Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 724286
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152226Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74366
ClinVar
Submissions by phenotype
Mucopolysaccharidosis, MPS-III-A Pathogenic:6
Likely pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Nov 07, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 11, 2022 | Variant summary: SGSH c.703G>A (p.Asp235Asn) results in a conservative amino acid change located in the Sulfatase, N-terminal domain (IPR000917) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.7e-05 in 237402 control chromosomes (gnomAD). c.703G>A has been reported in the literature in compound heterozygous individuals affected with Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome A) (Beesley_2000, Lee-Chen_2002, Heron_2011). These data indicate that the variant is likely to be associated with disease. A different variant affecting the same codon (Asp235Val) has been reported in affected individuals, suggesting this may be an important residue (Beesley_2000). One publication reports that the variant protein has 1.7% N-Sulphatase activity (Lee-Chen_2002). Three ClinVar submitters have assessed the variant since 2014: two classify the variant as likely pathogenic and one as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics | Oct 21, 2024 | A homozygous variation in exon 6 of the SGSH gene that results in the amino acid substitution of Asparagine for Aspartic acid at codon 235 was detected. The observed variant c.703G>A (p.Asp235Asn) has not been reported in the 1000 genomes and has a MAF of 0.0017% in the gnomAD database. The in-silico prediction of the variant is disease causing by Mutation Taster, PolyPhen2, DANN and Polyphen2. In summary, the variant meets our criteria to be classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 22, 2023 | This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 235 of the SGSH protein (p.Asp235Asn). This variant is present in population databases (rs753472891, gnomAD 0.02%). This missense change has been observed in individual(s) with mucopolysaccharidosis type III (PMID: 11182930, 12000360, 19099774; Invitae). ClinVar contains an entry for this variant (Variation ID: 553004). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SGSH protein function. Experimental studies have shown that this missense change affects SGSH function (PMID: 12000360). This variant disrupts the p.Asp235 amino acid residue in SGSH. Other variant(s) that disrupt this residue have been observed in individuals with SGSH-related conditions (PMID: 9401012), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 30, 2024 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Jul 27, 2017 | - - |
SGSH-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 13, 2022 | The SGSH c.703G>A variant is predicted to result in the amino acid substitution p.Asp235Asn. This variant along with a second variant in SGSH was reported in multiple individuals with Sanfilippo syndrome IIIA (also known as Sanfilippo A) (Beesley et al. 2000. PubMed ID: 11182930; Zhang et al. 2008. PubMed ID: 19099774; Lee-Chen et al. 2002. PubMed ID: 12000360; Table S2, HΓ©ron et al. 2011. PubMed ID: 21204211; Delgadillo et al. 2013. PubMed ID: 24314109). In addition, a different variant affecting the same amino acid (p.Asp235Val) was reported to be pathogenic for Sanfilippo syndrome A (Bunge et al. 1997. PubMed ID: 9401012). Structure and computational predication studies suggest this variant disrupts enzyme activity (Sidhu et al. 2014. PubMed ID: 24816101; Ugrinov et al. 2015. PubMed ID: 25807448). This variant is reported in 0.015% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/17-78187645-C-T). This variant is interpreted as pathogenic. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 03, 2024 | Published functional studies demonstrate a damaging effect (Western blot analysis revealed that precursor and mature protein were expressed at significantly lower levels and residual enzyme activity was 1.7% of controls) (PMID: 12000360); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31589614, 25807448, 24816101, 11182930, 12000360, 36972941, 35629088) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at